Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-05

FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a generic version of neostigmine methylsulfate from Meitheal Pharmaceuticals Inc. for its approved uses in treating myasthenia gravis and rever…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine Methylsulfate (neostigmine methylsulfate)

Snippet

ORIG AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)